Franklin Resources’s Global Blood Therapeutics, Inc. GBT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q3
Sell
-469,444
Closed -$15M 2440
2022
Q2
$15M Sell
469,444
-137,882
-23% -$4.41M 0.01% 861
2022
Q1
$21M Sell
607,326
-3,584
-0.6% -$124K 0.01% 846
2021
Q4
$17.9M Sell
610,910
-1,078,219
-64% -$31.6M 0.01% 922
2021
Q3
$43M Sell
1,689,129
-566,863
-25% -$14.4M 0.02% 694
2021
Q2
$79M Buy
2,255,992
+65,147
+3% +$2.28M 0.03% 519
2021
Q1
$89.3M Buy
2,190,845
+883
+0% +$36K 0.04% 461
2020
Q4
$94.8M Buy
2,189,962
+262,925
+14% +$11.4M 0.04% 441
2020
Q3
$106M Buy
1,927,037
+677,250
+54% +$37.3M 0.05% 363
2020
Q2
$90.1M Buy
1,249,787
+284,628
+29% +$20.5M 0.05% 400
2020
Q1
$49.3M Sell
965,159
-121,117
-11% -$6.19M 0.03% 465
2019
Q4
$86.3M Sell
1,086,276
-404,586
-27% -$32.2M 0.05% 411
2019
Q3
$72.3M Buy
1,490,862
+78,553
+6% +$3.81M 0.04% 449
2019
Q2
$74.3M Buy
1,412,309
+704,956
+100% +$37.1M 0.04% 456
2019
Q1
$37.4M Buy
707,353
+8
+0% +$423 0.02% 588
2018
Q4
$29M Sell
707,345
-155,463
-18% -$6.38M 0.02% 616
2018
Q3
$32.8M Buy
862,808
+123,179
+17% +$4.68M 0.02% 644
2018
Q2
$33.4M Buy
739,629
+118,029
+19% +$5.33M 0.02% 635
2018
Q1
$30M Buy
+621,600
New +$30M 0.02% 673